
Pomerantz LLP Launches Inquiry into Dr. Reddy’s Laboratories
A 9.4% drop in stock value following a disappointing quarterly earnings report has triggered a formal investigation by Pomerantz LLP into Dr. Reddy’s Laboratories. The New York-based law firm is examining potential securities fraud and unlawful business practices involving the company's executive leadership and board of directors.
























